We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AEM icon
126
Agnico Eagle Mines
AEM
$72.6B
$27.5M 0.2%
230,868
-55,750
-19% -$6.47M
DIS icon
127
Walt Disney
DIS
$165B
$27.3M 0.19%
220,485
-6,158
-3% -$640K
FYBR
128
DELISTED
Frontier Communications
FYBR
$27.3M 0.19%
750,299
+100,516
+15% +$3.65M
BA icon
129
Boeing
BA
$165B
$27.2M 0.19%
129,698
+60
+0% +$11.3K
BPMC
130
DELISTED
Blueprint Medicines
BPMC
$27.1M 0.19%
+211,169
New +$21.9M
MCO icon
131
Moody's
MCO
$81.7B
$26M 0.18%
51,887
-12
-0% -$5.56K
SLB icon
132
SLB Ltd
SLB
$77.8B
$25.8M 0.18%
763,938
-560
-0.1% -$19.4K
MRK icon
133
Merck
MRK
$324B
$25.8M 0.18%
326,115
-23,500
-7% -$1.87M
CRWD icon
134
CrowdStrike
CRWD
$187B
$25.7M 0.18%
201,700
-9,208
-4% -$998K
CEG icon
135
Constellation Energy
CEG
$98B
$25.4M 0.18%
78,817
-3,050
-4% -$807K
BX icon
136
Blackstone
BX
$104B
$25.4M 0.18%
169,864
-5,392
-3% -$741K
KMI icon
137
Kinder Morgan
KMI
$73.1B
$25.3M 0.18%
860,100
+182,100
+27% +$5M
BMI icon
138
Badger Meter
BMI
$3.66B
$25.1M 0.18%
102,400
-1,400
-1% -$317K
JNPR
139
DELISTED
Juniper Networks
JNPR
$25.1M 0.18%
628,072
+19,900
+3% +$713K
ASML icon
140
ASML
ASML
$675B
$25M 0.18%
31,239
+15
+0% +$10.8K
C icon
141
Citigroup
C
$222B
$24.8M 0.18%
290,820
-27,035
-9% -$1.95M
BF.A icon
142
Brown-Forman Class A
BF.A
$12.3B
$24.7M 0.18%
900,900
-27,400
-3% -$879K
GEF icon
143
Greif
GEF
$4.47B
$24.7M 0.18%
379,950
-1,000
-0.3% -$56.9K
EGO icon
144
Eldorado Gold
EGO
$8.31B
$24.4M 0.17%
1,200,700
-353,500
-23% -$6.88M
AGI icon
145
Alamos Gold
AGI
$12.4B
$24.4M 0.17%
917,975
-133,700
-13% -$3.57M
THC icon
146
Tenet Healthcare
THC
$20.1B
$24.2M 0.17%
137,435
-41,015
-23% -$6.17M
MGEE icon
147
MGE Energy Inc
MGEE
$3.11B
$24.1M 0.17%
272,800
-1,100
-0.4% -$99K
HSIC icon
148
Henry Schein
HSIC
$9.74B
$24.1M 0.17%
329,336
-16,750
-5% -$1.15M
D icon
149
Dominion Energy
D
$62.5B
$24M 0.17%
424,900
-7,100
-2% -$389K
LHX icon
150
L3Harris
LHX
$55.9B
$24M 0.17%
95,624
-50
-0.1% -$11.5K
4 5
6
7 8

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.